Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

SOPHiA GENETICS (SOPH) Other Gross PP&E Adjustments (2020 - 2025)

SOPHiA GENETICS's Other Gross PP&E Adjustments history spans 6 years, with the latest figure at -$7.0 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 21.68% to -$7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.0 million, a 21.68% increase, with the full-year FY2025 number at -$7.0 million, up 21.68% from a year prior.
  • Other Gross PP&E Adjustments hit -$7.0 million in Q4 2025 for SOPHiA GENETICS, up from -$7.8 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for SOPH hit a ceiling of -$3.1 million in Q2 2021 and a floor of -$11.5 million in Q3 2021.
  • Historically, Other Gross PP&E Adjustments has averaged -$8.0 million across 5 years, with a median of -$8.1 million in 2024.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 232.28% in 2021 and later rose 21.68% in 2025.
  • Tracing SOPH's Other Gross PP&E Adjustments over 5 years: stood at -$6.6 million in 2021, then decreased by 7.69% to -$7.1 million in 2022, then fell by 14.39% to -$8.2 million in 2023, then decreased by 9.71% to -$9.0 million in 2024, then rose by 21.68% to -$7.0 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for SOPH at -$7.0 million in Q4 2025, -$7.8 million in Q3 2025, and -$8.2 million in Q2 2025.